AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

BIO-TECHNE Corp Director's Dealing 2014

Nov 3, 2014

30718_dirs_2014-11-03_af0298e7-0714-416c-984c-f8978337dcb7.zip

Director's Dealing

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2014-10-30

Reporting Person: OCONNELL HOWARD V (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-10-30	Common Stock	A	1000	—	Acquired	2000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-10-30	Stock Option (right to buy)	$91.78	A	4000	Acquired	2024-10-30	Common Stock (4000)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	70000	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Optoin (right to buy)	$87.39	2023-10-30	Common Stock (4000)	4000	Indirect
Stock Option (right to buy)	$66.90	2022-10-24	Common Stock (5000)	5000	Indirect
Stock Option (right to buy)	$70.35	2021-10-26	Common Stock (5000)	5000	Indirect
Stock Option (right to buy)	$61.46	2020-10-27	Common Stock (5000)	5000	Indirect
Stock Option (right to buy)	$63.03	2019-10-28	Common Stock (5000)	5000	Indirect
Stock Option (right to buy)	$65.47	2018-10-22	Common Stock (5000)	5000	Indirect
Stock Option (right to buy)	$66.59	2017-10-24	Common Stock (5000)	5000	Indirect
Stock Option (right to buy)	$56.17	2016-10-25	Common Stock (5000)	5000	Indirect